Nebivolol induces, via β3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes

Journal of Hypertension

Volumn 32, Issue 2, 2014, Pages 389-396

  Bordicchia, Marica ^a   Pocognoli, Antonella ^a   D'Anzeo, Marco ^a   Siquini, Walter ^b   Minardi, Daniele ^b   Muzzonigro, Giovanni ^b   Dessì Fulgheri, Paolo ^a   Sarzani, Riccardo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

human adipocytes; nebivolol; uncoupling protein; 3 adrenergic receptor

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOCHROME C; FAT DROPLET; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEBIVOLOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROPRANOLOL; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENANTIOMER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAABDOMINAL FAT; LIPOLYSIS; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN FUNCTION; PROTEIN INDUCTION; SUBCUTANEOUS FAT; THERMOGENESIS;

ADIPOCYTES; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-3 RECEPTOR AGONISTS; ADRENERGIC BETA-3 RECEPTOR ANTAGONISTS; AGED; AGED, 80 AND OVER; BENZOPYRANS; CELL SIZE; ETHANOLAMINES; FEMALE; HUMANS; ION CHANNELS; LIPID METABOLISM; LIPOLYSIS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-3;

EID: 84893023959     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000024     Document Type: Article

References (43)

1. Rizos E, Bairaktari E, Kostoula A, Hasiotis G, Achimastos A, Ganotakis E, et al. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study. J Cardiovasc Pharmacol Ther 2003; 8: 127-134.
2. Marazzi G, Volterrani M, Caminiti G, Iaia L, Cacciotti L, Massaro R, et al. Effectiveness of nebivolol and hydrochlorothiazide association on blood pressure, glucose, and lipid metabolism in hypertensive patients. Adv Ther 2010; 27:655-664.
3. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fegard R, Germano G, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
4. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelineson hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
5. Ignarro LJ. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol. Cardiovasc Ther 2008; 26:115-134.
6. Tran Quang T, Rozec B, Audigane L, Gauthier C. Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta. Br J Pharmacol 2009; 156:601-608.
7. Dessy C, Moniotte S, Ghisdal P, Havaux X, Noirhomme P, Balligand JL. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation 2004; 110:948-954.
8. Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C. Nebivolol, a vasodilating selective beta (1)-blocker, is a beta (3)-adrenoceptor agonist in the non failing transplanted human heart. J Am Coll Cardiol 2009; 53:1532-1538.
9. Dessy C, Saliez J, Ghisdal P. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary micro-vessels in response to the third-generation beta-blocker nebivolol. Circulation 2005; 112:1198-1205.
10. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional beta3-adrenoceptor in the human heart. J Clin Invest 1996; 98:556-562.
11. Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, et al. The negative inotropic effect of (3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 1998; 102:1377-1384.
12. Soeder KJ, Snedden SK, Cao W, Della Rocca GJ, Daniel KW, Luttrell LM, Collins S. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J Biol Chem 1999; 274:12017-12022.
13. Lönnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P. Evidence for a functional beta 3-adrenoceptor in man. Br J Pharmacol 1993; 110:929-936.
14. Lönnqvist F, Thöme A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest 1995; 95:1109-1116.
15. De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ. Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 2002; 26:1442-1450.
16. Yehuda-Shnaidman E, Buehrer B, Pi J, Kumar N, Collins S. Acute stimulation of white adipocyte respiration by PKA-induced lipolysis. Diabetes 2010; 59:2474-2483.
17. Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 2003; 24:276-283.
18. Ricquier D, Bouillaud F, Toumelin P, Mory G, Bazin R, Arch J, Pénicaud L. Expression of uncoupling protein mRNA in thermogenic or weakly thermogenic brown adipose tissue. Evidence for a rapid beta-adrenoreceptor-mediated and transcriptionally regulated step during activation of thermogenesis. J Biol Chem 1986; 261:13905-13910.
19. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009; 360:1500-1508.
20. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009; 360:1509-1517.
21. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009; 360:1518-1525.
22. Frontini A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab 2010; 11:253-256.
23. Cannon B, Nedergaard J. Brown adipose tissue: function and phisio-logycal significance. Physiol Rev 2004; 84:277-359.
24. Granneman JG, Li P, Zhu Z, Lu Y. Metabolic and cellular plasticity in white adipose tissue I: effects of b3-adrenergic receptor activation. Am J Physiol Endocrinol Metab 2005; 289:E608-E616.
25. Tavernier G, Barbe P, Galitzky J, Berlan M, Caput D, Lafontan M, Langin D. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipid Res 1996; 37:87-97.
26. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dess̀i-Fulgheri P, Zhang C, Takahashi N, et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012; 122:1022-1036.
27. Chamberlain PD, Jennings KH, Paul F, Cordell J, Berry A, Holmes SD, et al. The tissue distribution of the human b3-adrenoceptor studies using a monoclonal antibody. Int J Obes Relat Metab Disord 1999; 23:1057-1065.
28. Sarzani R, Marcucci P, Salvi F, Bordicchia M, Espinosa E, Mucci L, et al. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int J Obes 2008; 32:259-267.
29. Barbatelli G, Murano I, Madsen L, Hao Q, Jimenez M, Kristiansen K, et al. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab 2010; 298:E1244-E1253.
30. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, et al. Alternatively activated macrophages produce catecholaminesto sustain adaptive thermogenesis. Nature 2011; 480:104-108.
31. Sorriento D, Santulli G, Del Giudice C, Anastasio A, Trimarco B, Iaccarino G. Endothelial cells are able to synthesize and release cate-cholamines both in vitro and in vivo. Hypertension 2012; 60:129-136.
32. Ma S, Yu H, Zhao Z, Luo Z, Chen J, Ni Y, et al. Activation of the cold-sensing TRPM8 channel triggers UCP1-dependent thermogenesis and prevents obesity. J Mol Cell Biol 2012; 4:88-96.
33. Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, et al. p38 MAP kinase is the central regulator of cAMP-dependent transcription of the brown fat uncoupling protein-1 gene. Mol Cell Biol 2004; 24:3057-3067.
34. Cao W, Medvedev AV, Daniel KW, Collins S. B-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein-1 (UCP1) gene requires p38 MAP kinase. J Biol Chem 2001; 276:27077-27082.
35. Feng MG, Prieto MC, Navar LG. Nebivolol induced vasodilation of renal afferent arterioles involves (3 adrenergic receptor and nitric oxide synthase activation. Am J Physiol Renal Physiol 2012; 303:F775-F782.
36. Rohlfs EM, Daniel KW, Premont RT, Kozak LP, Collins S. Regulation of the uncoupling protein gene (Ucp) by beta 1, beta 2, and beta 3-adrenergic receptor subtypes in immortalized brown adipose cell lines. J Biol Chem 1995; 270:10723-10732.
37. Nagase I, Yoshida T, Kumamoto K, Umekawa T, Sakane N, Nikami H, et al. Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist. J Clin Invest 1996; 97:2898-2904.
38. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 1998; 102:412-420.
39. Manrique C, Whaley-Connell A, Sowers JR. Nebivolol in obese and nonobese hypertensive patients. J Clin Hypertens 2009; 11:309-315.
40. vanVeldhuisen DJ, Cohen-Solal A, Bohm M, Anker SD, Babalis D, Roughton M, et al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Zhou et al. Page 8 Hypertension. Author manuscript; available in PMC 2010 May 1. Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 2009; 53: 2150-2158.
41. Uldry M, yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab 2006; 3:333-341.
42. Golozoubova V, Cannon B, Nedergaard J. UCP1 is essential for adaptive adrenergic nonshivering thermogenesis. Am J Physiol Endo-crinol Metab 2006; 291:E350-E357.
43. Redman LM, de Jonge L, Fang X, Gamlin B, Recker D, Greenway FL, et al. Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study. J Clin Endocrinol Metab 2007; 92:527-531.